Depomed (DEPO) Tops Q3 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Nasdaq, S&P 500 slip from record highs as yields and oil rebound
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
WallachBeth Capital Upgrades DepoMed Inc (DEPO) to Buy
November 11, 2015 7:34 AM ESTWallachBeth Capital upgraded DepoMed Inc (NASDAQ: DEPO) from Hold to Buy with a price target of $33.00.
For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.
Shares of DepoMed Inc closed at $21.21 yesterday.
... MoreDepomed (DEPO) Reports 3Q EPS Beat; Janney Capital Reiterates Buy
November 10, 2015 9:25 AM ESTJanney Capital reiterated a Buy rating and $35.00 price target on DepoMed Inc (NASDAQ: DEPO) following the company's 3Q earnings report. DEPO reports $104.9 mln in revenues and non-GAAP adjusted EPS of $0.33, easily beating consensus estimates of $$101.64 mln and non-GAAP adjusted earnings of $0.19 per share.
Analyst... More



